Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Illumina, Inc. (ILMN) vs Victoria's Secret & Co (VSXY) Price & Performance

Illumina, Inc.Trade
Victoria's Secret & CoTrade

Price performance (Past 24H)

Key statistics

Illumina, Inc. vs Victoria's Secret & Co — how do they compare? Illumina, Inc. trades at $278.17 (market cap $39.95B), while Victoria's Secret & Co trades at $82.87 (market cap $6.91B). The key difference: Illumina, Inc. is far larger — about 5.8× Victoria's Secret & Co's market cap, and Illumina, Inc. is trading nearer its 52-week high, Victoria's Secret & Co nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Victoria's Secret & Co for 34 Days on average.

ILMNVSXY
Market Cap
$39.95B$6.91B
Volume
3,169,5031,346,928
Sector
HealthConsumer Cyclical
52-Week High
$293.69$99.97
52-Week Low
$91.00$28.25
Typical Hold Time
83 Days34 Days
Enterprise Value
$41.31B$9.29B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Illumina, Inc.

Illumina (ILMN) trades at $264.40, down 1.25% on the day but remains near its 52-week high of $278.99, reflecting strong momentum with a 94.9% YTD gain. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Fundamentals show a significant turnaround, with net income reaching $850 million in 2025 after prior losses, supported by robust gross margins of 66.38%. Technical indicators are bullish overall, with key support at $257 and resistance at $268.

The outlook for ILMN is positive, driven by earnings momentum, inclusion in the S&P 500, and strategic AI initiatives in genomics. However, risks include high valuation multiples, such as a P/E of 49.36, and potential margin pressure from cost volatility. Analyst consensus is bullish with a 54% buy rating, though the consensus price target of $241 suggests limited near-term upside from current levels.

Victoria's Secret & Co

Victoria's Secret (VSXY) trades at $86.61, up 0.96% with strong technical momentum and bullish moving average signals. The company demonstrates improving fundamentals with three consecutive quarterly earnings beats and a projected 2026 net income rebound to $378M. Recent news highlights brand momentum through fashion show expansion and omnichannel growth, though valuation remains elevated at P/E 19.33.

The outlook appears positive with 60% analyst buy ratings and $86.80 consensus target, but risks include rich valuation, rising costs, and competitive pressures. Earnings growth acceleration and international expansion provide catalysts, while margin sustainability and consumer demand volatility present challenges for sustained shareholder returns.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ILMN

No sentiment data available yet.

VSXY
96% Buy4% Sell
Avg holding period · 34 Days

Top news

Latest headlines on both assets

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Read more on ILMN →

About Victoria's Secret & Co

Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.

Read more on VSXY →